We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Epidemiologic Data of Patients in a Teaching Hospital

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00114335
Recruitment Status : Completed
First Posted : June 15, 2005
Last Update Posted : October 10, 2008
Sponsor:
Information provided by:
Luzerner Kantonsspital

Brief Summary:

This small cross-sectional epidemiological study is designed to evaluate the prevalence of the following parameters in hospitalized patients in a tertiary teaching hospital (medical department only):

  • kidney insufficiency
  • obesity
  • use of unfractionated heparins / low molecular weight heparins
  • other drugs effecting the hemostatic system

Condition or disease
Kidney Diseases Obesity

Detailed Description:

This small cross-sectional epidemiological study is designed to evaluate the prevalence of the following parameters in hospitalized patients in a tertiary teaching hospital (medical department only):

  • kidney insufficiency
  • obesity
  • use of unfractionated heparins / low molecular weight heparins
  • other drugs effecting the hemostatic system

Study Type : Observational
Actual Enrollment : 352 participants
Observational Model: Cohort
Time Perspective: Cross-Sectional
Official Title: Prevalence of Impaired Renal Function in Medical Inpatients
Study Start Date : May 2005
Study Completion Date : July 2005




Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
All patients hospitalized at the defined days (two days) at Kantonsspital Luzern, Department of Medicine
Criteria

Inclusion Criteria:

  • All patients hospitalized at the defined days (two days) at Kantonsspital Luzern, Department of Medicine

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00114335


Locations
Switzerland
Kantonsspital Luzern
Luzern, LU, Switzerland, 6000
Sponsors and Collaborators
Luzerner Kantonsspital
Investigators
Principal Investigator: P Schmid, MD Kantonsspital Luzern, Hematology
Study Director: A G Fischer, MD Kantonsspital Luzern, Nephrology
Study Chair: W A Wuillemin, MD, PhD Kantonsspital Luzern, Hematology

Additional Information:
Publications:
ClinicalTrials.gov Identifier: NCT00114335     History of Changes
Other Study ID Numbers: LMWHplus_1
First Posted: June 15, 2005    Key Record Dates
Last Update Posted: October 10, 2008
Last Verified: October 2008

Keywords provided by Luzerner Kantonsspital:
low molecular weight heparin
unfractionated heparin

Additional relevant MeSH terms:
Kidney Diseases
Urologic Diseases